Deals & Corporate Governance
- 
									January 17, 2025
									PE Firm Resolves FTC's Antitrust Anesthesia Roll-Up CasePrivate equity firm Welsh Carson Anderson & Stowe agreed to limit its involvement, entanglement and ownership rights with its portfolio company U.S. Anesthesia Partners Inc. to resolve allegations they engaged in a "roll-up" scheme to buy anesthesiology practices in Texas and drive up costs, the Federal Trade Commission said Friday. 
- 
									January 17, 2025
									Crown Labs Tops Rival Bid In Quest To Buy Biotech RevanceSkincare product company Crown Laboratories Inc. has offered to raise its all-cash bid to buy healthcare biotech company Revance Therapeutics Inc. from $3.10 per share to $3.65 per share as it seeks to beat out a surprise bid from a Revance shareholder, according to a securities filing on Friday. 
- 
									January 16, 2025
									EpiPen Direct Buyers, Mylan Ink $75M Antitrust DealMylan Pharmaceuticals has agreed to pay $73.5 million to resolve claims it worked with Pfizer to inflate the price of the latter's popular auto-injecting emergency allergy medication EpiPen, a proposed class of direct purchasers told a Kansas federal judge Wednesday, bringing the total settlement to $123.5 million. 
- 
									January 15, 2025
									Del. Justices Mull 'Reasonable' Effort Duty In Drug Biz DealAn attorney for former stockholders of Ception Therapeutics Inc. told Delaware's top court on Wednesday that a now-retired vice chancellor "asked the wrong question" in dismissing a suit alleging breaches of an agreement to use commercially reasonable efforts before abandoning a new drug prospect. 
- 
									January 14, 2025
									Healthcare Deals To Be More 'Rational' In 2025, Panel SaysHealthcare deals will become more "rational" this year as buyers and sellers find more middle ground on valuations, experts said, potentially shaping a more optimistic landscape for transactions in the space. 
- 
									January 14, 2025
									Fed. Circ. Judge Asks What's The Rush In Eylea Biosimilar CaseCounsel for Amgen and a Federal Circuit judge got into a back-and-forth Tuesday concerning the pace of an appeal over a denied injunction on Regeneron's biosimilar of Eylea, with the judge wondering why the attorney was so eager to move things along. 
- 
									January 14, 2025
									Chancery Hits Co. With $2.9M Atty Fee Bill As SanctionA California medical device molding company that sought millions from a merger partner for breaches of contract in Delaware's Court of Chancery came away Tuesday with awards of $104,000 for its claims and $2.9 million in attorney fees as a sanction for contempt and spoliation by Symbient Product Development LLC founder Scott Castanon. 
- 
									January 14, 2025
									JPM Health Conference Days 1-2: What You Need To KnowThe J.P. Morgan Healthcare Conference kicked off in San Francisco, with surprisingly good weather and a handful of blockbuster announcements to open the industry's premier deals conference. 
- 
									January 14, 2025
									MedQuest Adds Health System In-House Vet As Top AttyMedQuest Associates, an operator of outpatient diagnostic imaging facilities across the U.S., is welcoming a new chief legal officer who brings nearly three decades of experience working with healthcare organizations. 
- 
									January 13, 2025
									Meet The Attorneys Advising Prospect Medical In Ch. 11A team of attorneys from Sidley Austin LLP is representing California-based hospital operator Prospect Medical Holdings Inc. in its Chapter 11 case in Texas, as the company aims to sell several facilities while refocusing on operations in its home state. 
- 
									January 13, 2025
									Proskauer Faces Revived DQ Bid In NJ Hospital Antitrust FightCarePoint Health is once again pushing to have Proskauer Rose LLP disqualified as counsel for healthcare network RWJBarnabas Health Inc. in an antitrust lawsuit in New Jersey federal court, asserting that a magistrate judge erred in previously denying its request. 
- 
									January 13, 2025
									Cravath-Led J&J Paying $14.6B For Neuropsychiatric Drug Co.Johnson & Johnson said Monday it has agreed to purchase Intra-Cellular Therapies Inc., a biopharmaceutical company focused on therapies for neuropsychiatric and neurological disorders, for approximately $14.6 billion. 
- 
									January 10, 2025
									Taxation With Representation: Kirkland, Davis Polk, WachtellIn this week's Taxation With Representation, Constellation acquires Calpine, Cintas seeks a deal with UniFirst Corp., Stryker Corp. acquires Inari Medical Inc., and Paychex Inc. buys Paycor. 
- 
									January 10, 2025
									BCLP's Global Healthcare Chair Jumps To DechertDechert LLP has brought on the former global chair of healthcare and life sciences at Bryan Cave Leighton Paisner LLP as a corporate and securities partner and leader of its healthcare regulatory practice. 
- 
									January 09, 2025
									Amgen Says Enbrel Protected By Legit Patents, RulingsAmgen has asked a Virginia federal judge to permanently toss the latest version of a proposed class action accusing it of illegally entrenching and expanding patent rights to stave off cheaper competition for Enbrel, arguing the blockbuster arthritis treatment is protected by legitimate patents and court rulings of validity. 
- 
									January 09, 2025
									Cancer Org Fails To Get Rival's TM Counterclaims TossedA Georgia federal judge said Thursday that the Glioblastoma Foundation Inc. can't yet escape a series of counterclaims filed against it by a rival nonprofit amid a trademark spat, ruling that its defenses in a dismissal bid largely relied on factual issues about whether the rival fraudulently obtained the marks at issue. 
- 
									January 09, 2025
									Yale Wins Info Battle In $435M Hospital Sale Contract FightThree Connecticut property owners must hand over internal analyses and communications to Yale New Haven Health Services Corp. as it seeks evidence in support of its bid to back out of a $435 million deal to purchase hospitals from Prospect Medical Holdings Inc., a state court judge ruled. 
- 
									January 08, 2025
									Colo. Judge Certifies National Class Of Senior Care InvestorsA Colorado federal judge on Wednesday certified a nationwide class of stockholders in a securities suit alleging a senior health care company made misleading statements in an initial public offering that later caused stock prices to tank after a government audit exposed the falsehoods. 
- 
									January 08, 2025
									Boston Scientific Paying Up To $664M For Bolt MedicalBoston Scientific Corp. said Wednesday it plans to acquire the remaining stake it does not own in Bolt Medical Inc., the developer of a proprietary laser-based treatment for coronary and peripheral artery disease, for up to $664 million. 
- 
									January 08, 2025
									Wilson Sonsini, Cooley Lead $621M Take-Private Of AccoladePrivate equity-backed healthcare company Transcarent, advised by Wilson Sonsini Goodrich & Rosati PC, and personalized healthcare company Accolade, led by Cooley LLP, on Wednesday announced plans to merge in a $621 million deal that will result in Accolade becoming a private company. 
- 
									January 07, 2025
									Obesity Drug Maker Faces Investor Suit Over IPO DisclosuresBiopharmaceutical company BioAge Labs Inc. is facing a proposed class action alleging investors in its initial public offering were hurt by plummeting share prices after the company unexpectedly hit the brakes on a clinical trial for its lead product candidate. 
- 
									January 07, 2025
									Healthcare Deals This Week: Novo Nordisk, Roche, DualityBioThe first week of 2025 started off slow for the healthcare industry, but began to pick up steam as the first Monday of the new year rolled around. 
- 
									January 07, 2025
									McDermott Picks New Healthcare Leader, Rebrands GroupMcDermott Will & Emery LLP is revamping its healthcare practice. 
- 
									January 06, 2025
									Sidley, Wachtell Guide Inari Medical's $4.9B Sale To StrykerMedical technology company Stryker Corp., represented by Sidley Austin LLP, announced Monday that it has inked an agreement to acquire device maker Inari Medical Inc., represented by Wachtell Lipton Rosen & Katz, in a deal worth about $4.9 billion. 
- 
									January 06, 2025
									Biotech Trade Secrets Case Gets New Punitive Damages TrialA California federal judge has ordered a new punitive damages trial on how much a former Skye Orthobiologics LLC employee owes in a case where he was found to have breached his fiduciary duties by leveraging Skye's proprietary information, after ruling last year there wasn't enough evidence to support an earlier $25 million award. 
Expert Analysis
- 
								
								Fla. Foreign Real Estate Law Brings Broad Investment Risks.jpg)  Last month, Florida became the latest state to enact legislation prohibiting Chinese investors from acquiring certain interests in real property, introducing significant legal uncertainty and consequences for real estate stakeholders and the private equity industry, say attorneys at Simpson Thacher. 
- 
								
								Tackling Judge-Shopping Concerns While Honoring Localism  As the debate continues over judge-shopping and case assignments in federal court, policymakers should look to a hybrid model that preserves the benefits of localism for those cases that warrant it, while preventing the appearance of judge-shopping for cases of a more national or widespread character, says Joshua Sohn at the U.S. Department of Justice. 
- 
								
								How Attorneys Can Help Combat Anti-Asian Hate  Amid an exponential increase in violence against Asian American and Pacific Islander communities, unique obstacles stand in the way of accountability and justice — but lawyers can effect powerful change by raising awareness, offering legal representation, advocating for victims’ rights and more, say attorneys at Gibson Dunn. 
- 
								
								Congress Needs To Enact A Federal Anti-SLAPP Statute  Although many states have passed statutes meant to prevent individuals or entities from filing strategic lawsuits against public participation, other states have not, so it's time for Congress to enact a federal statute to ensure that free speech and petitioning rights are uniformly protected nationwide in federal court, say attorneys at Skadden. 
- 
								
								Takeaways From New Fla. Pharmacy Benefit Manager Rules  A recently passed Florida law imposes several new requirements on pharmacy benefit managers, necessitating practical considerations that range from potential license application delays to possible trade secret exposure, say Thomas Range and Bruce Platt at Akerman. 
- 
								
								Looking For Plausibility In FTC's Amgen Merger Challenge  The Federal Trade Commission is seeking to block Amgen's acquisition of Horizon, alleging that, if consummated, the deal would violate Section 7 of the Clayton Act — but this may be the first merger complaint in a generation that could be dismissed for failing to state a claim, say William MacLeod and David Evans at Kelley Drye. 
- 
								
								Some Client Speculations On AI And The Law Firm Biz Model  Generative artificial intelligence technologies will put pressure on the business of law as it is structured currently, but clients may end up with more price certainty for legal services, and lawyers may spend more time being lawyers, says Jonathan Cole at Melody Capital. 
- 
								
								A Lawyer's Guide To Approaching Digital Assets In Discovery  The booming growth of cryptocurrency and non-fungible tokens has made digital assets relevant in many legal disputes but also poses several challenges for discovery, so lawyers must garner an understanding of the technology behind these assets, the way they function, and how they're held, says Brett Sager at Ehrenstein Sager. 
- 
								
								High Court's Ethics Statement Places Justices Above The Law.jpg)  The U.S. Supreme Court justices' disappointing statement on the court's ethics principles and practices reveals that not only are they satisfied with a status quo in which they are bound by fewer ethics rules than other federal judges, but also that they've twisted the few rules that do apply to them, says David Janovsky at the Project on Government Oversight. 
- 
								
								Time For Law Schools To Rethink Unsung Role Of Adjuncts-(1).jpg)  As law schools prepare for the fall 2023 semester, administrators should reevaluate the role of the underappreciated, indispensable adjunct, and consider 16 concrete actions to improve the adjuncts' teaching experience, overall happiness and feeling of belonging, say T. Markus Funk at Perkins Coie, Andrew Boutros at Dechert and Eugene Volokh at UCLA. 
- 
								
								Tips For In-House Legal Leaders In A Challenging Economy  Amid today's economic and geopolitical uncertainty, in-house legal teams are running lean and facing increased scrutiny and unique issues, but can step up and find innovative ways to manage outcomes and capitalize on good business opportunities, says Tim Parilla at LinkSquares. 
- 
								
								What Associates Need To Know Before Switching Law FirmsExcerpt from Practical Guidance  The days of staying at the same firm for the duration of one's career are mostly a thing of the past as lateral moves by lawyers are commonplace, but there are several obstacles that associates should consider before making a move, say attorneys at HWG. 
- 
								
								A Case For Sharing Mediation Statements With Counterparties  In light of a potential growing mediation trend of only submitting statements to the mediator, litigants should think critically about the pros and cons of exchanging statements with opposing parties as it could boost the chances of reaching a settlement, says Arthur Eidelhoch at Eidelhoch Mediation.